Published in Infect Immun on February 01, 1981
Antimicrobial defensin peptides form voltage-dependent ion-permeable channels in planar lipid bilayer membranes. Proc Natl Acad Sci U S A (1990) 3.90
Antibacterial activity of microbicidal cationic proteins 1 and 2, natural peptide antibiotics of rabbit lung macrophages. Infect Immun (1983) 2.33
Describing the mechanism of antimicrobial peptide action with the interfacial activity model. ACS Chem Biol (2010) 2.27
Activity of rabbit leukocyte peptides against Candida albicans. Infect Immun (1985) 2.05
Fungistatic and fungicidal activity of human parotid salivary histidine-rich polypeptides on Candida albicans. Infect Immun (1984) 1.95
Interaction of macrophage cationic proteins with the outer membrane of Pseudomonas aeruginosa. Infect Immun (1988) 1.92
Macrophages in resistance to candidiasis. Microbiol Mol Biol Rev (1997) 1.74
Increased content of microbicidal cationic peptides in rabbit alveolar macrophages elicited by complete Freund adjuvant. Infect Immun (1981) 1.52
Antifungal peptides: novel therapeutic compounds against emerging pathogens. Antimicrob Agents Chemother (1999) 1.48
Salivary histatin 5 and human neutrophil defensin 1 kill Candida albicans via shared pathways. Antimicrob Agents Chemother (2000) 1.16
Antimycobacterial agent based on mRNA encoding human beta-defensin 2 enables primary macrophages to restrict growth of Mycobacterium tuberculosis. Infect Immun (2001) 1.08
NP-1, a rabbit alpha-defensin, prevents the entry and intercellular spread of herpes simplex virus type 2. Antimicrob Agents Chemother (2003) 1.07
Antimicrobial activity of rabbit leukocyte defensins against Treponema pallidum subsp. pallidum. Infect Immun (1991) 0.97
Effect of zinc and phosphate on an antibacterial peptide isolated from lung lavage. Infect Immun (1984) 0.96
Heterogeneous activity of immature and mature cells of the murine monocyte-macrophage lineage derived from different anatomical districts against yeast-phase Candida albicans. Infect Immun (1986) 0.88
Candidacidal factors in murine bronchoalveolar lavage fluid. Infect Immun (1987) 0.81
Analysis and prediction of the critical regions of antimicrobial peptides based on conditional random fields. PLoS One (2015) 0.76
Protein measurement with the Folin phenol reagent. J Biol Chem (1951) 1743.91
Disk electrophoresis of basic proteins and peptides on polyacrylamide gels. Nature (1962) 20.19
Bactericidal action of histone. J Exp Med (1958) 6.58
Hydrogen peroxide release from mouse peritoneal macrophages: dependence on sequential activation and triggering. J Exp Med (1977) 5.44
Purification and characterization of a potent bactericidal and membrane active protein from the granules of human polymorphonuclear leukocytes. J Biol Chem (1978) 4.61
Oxygen-dependent microbial killing by phagocytes (second of two parts). N Engl J Med (1978) 4.31
The use of Coomassie Brilliant Blue G250 perchloric acid solution for staining in electrophoresis and isoelectric focusing on polyacrylamide gels. Anal Biochem (1975) 4.14
Macrophage oxygen-dependent antimicrobial activity. II. The role of oxygen intermediates. J Exp Med (1979) 3.72
Cationic proteins of polymorphonuclear leukocyte lysosomes. I. Resolution of antibacterial and enzymatic activities. J Bacteriol (1966) 3.61
Microbicidal cationic proteins in rabbit alveolar macrophages: a potential host defense mechanism. Infect Immun (1980) 3.13
Antibacterial activity of cationic proteins from human granulocytes. J Clin Invest (1975) 2.97
Nonoxidative fungicidal mechanisms of mammalian granulocytes: demonstration of components with candidacidal activity in human, rabbit, and guinea pig leukocytes. Infect Immun (1975) 2.68
Histones: structure and function. Annu Rev Biochem (1971) 2.23
The heterogeneity of histones. I. A quantitative analysis of calf histones in very long polyacrylamide gels. Biochemistry (1969) 2.07
Oxygen metabolism and the microbicidal activity of macrophages. Fed Proc (1978) 2.04
Cationic protein-bearing granules of polymorphonuclear leukocytes: separation from enzyme-rich granules. Science (1969) 2.00
Rubidium release: a rapid and sensitive assay for amphotericin B. J Infect Dis (1976) 1.76
Fungicidal properties of a chymotrypsin-like cationic protein from human neutrophils: adsorption to Candida parapsilosis. Infect Immun (1977) 1.61
Lysozyme: President's Address. Proc R Soc Med (1932) 1.14
Purification and properties of rabbit alveolar macrophage lysozyme. Infect Immun (1979) 1.00
Interaction of Candida albicans with human leukocytes and serum. J Bacteriol (1969) 9.19
Defensins. Natural peptide antibiotics of human neutrophils. J Clin Invest (1985) 8.63
Leukocyte myeloperoxidase deficiency and disseminated candidiasis: the role of myeloperoxidase in resistance to Candida infection. J Clin Invest (1969) 7.61
Purification and antibacterial activity of antimicrobial peptides of rabbit granulocytes. Infect Immun (1984) 5.30
Severe candidal infections: clinical perspective, immune defense mechanisms, and current concepts of therapy. Ann Intern Med (1978) 4.15
Phagocytosis by human monocytes. Blood (1968) 3.96
Antimicrobial defensin peptides form voltage-dependent ion-permeable channels in planar lipid bilayer membranes. Proc Natl Acad Sci U S A (1990) 3.90
Primary structures of three human neutrophil defensins. J Clin Invest (1985) 3.70
Primary structures of six antimicrobial peptides of rabbit peritoneal neutrophils. J Biol Chem (1985) 3.58
Activities of LL-37, a cathelin-associated antimicrobial peptide of human neutrophils. Antimicrob Agents Chemother (1998) 3.45
Widespread expression of beta-defensin hBD-1 in human secretory glands and epithelial cells. FEBS Lett (1996) 3.39
Protegrins: leukocyte antimicrobial peptides that combine features of corticostatic defensins and tachyplesins. FEBS Lett (1993) 3.30
Antifungal effects of peroxidase systems. J Bacteriol (1969) 3.24
Plasmid-mediated and temperature-regulated surface properties of Yersinia enterocolitica. Infect Immun (1983) 3.13
Role of a plasmid in the pathogenicity of Yersinia species. Curr Top Microbiol Immunol (1985) 3.13
Microbicidal cationic proteins in rabbit alveolar macrophages: a potential host defense mechanism. Infect Immun (1980) 3.13
Modulation of Neisseria gonorrhoeae susceptibility to vertebrate antibacterial peptides due to a member of the resistance/nodulation/division efflux pump family. Proc Natl Acad Sci U S A (1998) 3.02
Primary structures of MCP-1 and MCP-2, natural peptide antibiotics of rabbit lung macrophages. J Biol Chem (1983) 3.00
Direct inactivation of viruses by human granulocyte defensins. J Virol (1986) 3.00
Defensins. Eur J Haematol (1990) 2.88
A new fla gene in Salmonella typhimurium--flaR--and its mutant phenotype-superhooks. Arch Mikrobiol (1973) 2.80
Nonoxidative fungicidal mechanisms of mammalian granulocytes: demonstration of components with candidacidal activity in human, rabbit, and guinea pig leukocytes. Infect Immun (1975) 2.68
NADPH oxidase deficiency in X-linked chronic granulomatous disease. J Clin Invest (1975) 2.62
Defensins. Curr Opin Immunol (1994) 2.55
Defensins. Pharmacol Ther (1995) 2.52
Crystallization of antimicrobial pores in membranes: magainin and protegrin. Biophys J (2000) 2.41
Cryptdins: antimicrobial defensins of the murine small intestine. Infect Immun (1992) 2.39
Cyclic 3',5'-adenosine monophosphate in the human lukocyte: synthesis, degradation, andeffects n neutrophil candidacidal activity. J Clin Invest (1971) 2.35
Antibacterial activity of microbicidal cationic proteins 1 and 2, natural peptide antibiotics of rabbit lung macrophages. Infect Immun (1983) 2.33
Direct inactivation of viruses by MCP-1 and MCP-2, natural peptide antibiotics from rabbit leukocytes. J Virol (1985) 2.31
The fungicidal mechanisms of human monocytes. I. Evidence for myeloperoxidase-linked and myeloperoxidase-independent candidacidal mechanisms. J Clin Invest (1975) 2.26
Functional aspects of a second mechanism of candidacidal activity by human neutrophils. J Clin Invest (1972) 2.25
Defensins and other endogenous peptide antibiotics of vertebrates. J Leukoc Biol (1995) 2.25
Bactericidal activity of mammalian cathelicidin-derived peptides. Infect Immun (2000) 2.24
Modulation of the in vitro candidacidal activity of human neutrophil defensins by target cell metabolism and divalent cations. J Clin Invest (1988) 2.18
Susceptibility of Chlamydia trachomatis to protegrins and defensins. Infect Immun (1996) 2.16
Effects of cholera enterotoxin on adenosine 3',5'-monophosphate and neutrophil function. Comparison with other compounds which stimulate leukocyte adenyl cyclase. J Clin Invest (1973) 2.16
Assessment of chlorination by human neutrophils. Nature (1983) 2.12
Activity of rabbit leukocyte peptides against Candida albicans. Infect Immun (1985) 2.05
Development of amphotericin B-resistant Candida tropicalis in a patient with defective leukocyte function. Am J Med Sci (1979) 2.02
Mouse neutrophils lack defensins. Infect Immun (1992) 2.01
In vitro tumor cell cytolysis mediated by peptide defensins of human and rabbit granulocytes. Blood (1986) 2.01
The formation of bacterial flagella. 3. Characterization of the subunits of the flagella of Bacillus subtilis and Spirillum serpens. J Mol Biol (1967) 1.99
Antimicrobial peptides of vertebrates. Curr Opin Immunol (1998) 1.94
Correlation of binding of rabbit granulocyte peptides to Candida albicans with candidacidal activity. Infect Immun (1985) 1.89
Neutrophil defensins: purification, characterization, and antimicrobial testing. Methods Enzymol (1994) 1.88
Solution structure of protegrin-1, a broad-spectrum antimicrobial peptide from porcine leukocytes. Chem Biol (1996) 1.87
In vitro killing of spores and hyphae of Aspergillus fumigatus and Rhizopus oryzae by rabbit neutrophil cationic peptides and bronchoalveolar macrophages. J Infect Dis (1986) 1.84
Designer assays for antimicrobial peptides. Disputing the "one-size-fits-all" theory. Methods Mol Biol (1997) 1.79
Fungicidal activity of rabbit alveolar and peritoneal macrophages against Candida albicans. Infect Immun (1980) 1.79
Rubidium release: a rapid and sensitive assay for amphotericin B. J Infect Dis (1976) 1.76
Bactericidal properties of murine intestinal phospholipase A2. J Clin Invest (1995) 1.75
Phagolysosomal pH of human neutrophils. Blood (1984) 1.75
Effects of pH and salinity on the antimicrobial properties of clavanins. Infect Immun (1997) 1.75
Susceptibility of Neisseria gonorrhoeae to protegrins. Infect Immun (1996) 1.65
Antibacterial properties of eosinophil major basic protein and eosinophil cationic protein. J Immunol (1989) 1.64
Membrane thinning effect of the beta-sheet antimicrobial protegrin. Biochemistry (2000) 1.64
Mechanism of target cytolysis by peptide defensins. Target cell metabolic activities, possibly involving endocytosis, are crucial for expression of cytotoxicity. J Immunol (1988) 1.64
Microbicidal/cytotoxic proteins of neutrophils are deficient in two disorders: Chediak-Higashi syndrome and "specific" granule deficiency. J Clin Invest (1988) 1.63
Fungicidal properties of a chymotrypsin-like cationic protein from human neutrophils: adsorption to Candida parapsilosis. Infect Immun (1977) 1.61
Isolation and characterization of human defensin cDNA clones. Proc Natl Acad Sci U S A (1988) 1.61
Defensin-rich dense granules of human neutrophils. Blood (1987) 1.59
Arginine-rich cationic proteins of human eosinophil granules: comparison of the constituents of eosinophilic and neutrophilic leukocytes. Lab Invest (1977) 1.57
Defensins: a family of antimicrobial and cytotoxic peptides. Toxicology (1994) 1.53
Increased content of microbicidal cationic peptides in rabbit alveolar macrophages elicited by complete Freund adjuvant. Infect Immun (1981) 1.52
Antimicrobial proteins of murine macrophages. Infect Immun (1993) 1.50
Antimicrobial activity of phagocyte granule proteins. Semin Respir Infect (1986) 1.49
Purification and antimicrobial properties of three defensins from rat neutrophils. Infect Immun (1989) 1.46
Intramolecular disulfide bonds enhance the antimicrobial and lytic activities of protegrins at physiological sodium chloride concentrations. Eur J Biochem (1996) 1.45
Antibiotic peptides from higher eukaryotes: biology and applications. Mol Med Today (1999) 1.44
D-amino acid oxidase in leukocytes: a possible D-amino-acid-linked antimicrobial system. Proc Natl Acad Sci U S A (1969) 1.43
Phagocytosis by human eosinophils. Blood (1968) 1.42
Myeloperoxidase deficiency. Immunologic study of a genetic leukocyte defect. N Engl J Med (1970) 1.41
Uteroglobin/Clara cell 10-kDa family of proteins: nomenclature committee report. Ann N Y Acad Sci (2000) 1.41
Effects of colchicine and chloramphenicol on the oxidative metabolism and phagocytic activity of human neutrophils. J Infect Dis (1973) 1.40
Sequential metabolic expressions of the lethal process in human serum-treated Escherichia coli: role of lysozyme. Infect Immun (1980) 1.40
UCLA Conference. Monocytes and macrophages: functions and diseases. Ann Intern Med (1978) 1.38
A single amino acid substitution responsible for altered flagellar morphology. J Mol Biol (1968) 1.37
In vitro candidastatic properties of the human neutrophil calprotectin complex. J Immunol (1993) 1.37
In vitro activity of the antimicrobial peptides human and rabbit defensins and porcine leukocyte protegrin against Mycobacterium tuberculosis. Infect Immun (1996) 1.37
Membrane channel formation by antimicrobial protegrins. Biochim Biophys Acta (1999) 1.36
Multiple states of beta-sheet peptide protegrin in lipid bilayers. Biochemistry (1998) 1.36
Individual and synergistic effects of rabbit granulocyte proteins on Escherichia coli. J Clin Invest (1994) 1.34
Gallinacins: cysteine-rich antimicrobial peptides of chicken leukocytes. FEBS Lett (1994) 1.33
Antimicrobial peptides of leukocytes. Curr Opin Hematol (1997) 1.32
Activity of defensins from human neutrophilic granulocytes against Mycobacterium avium-Mycobacterium intracellulare. Infect Immun (1992) 1.32
Secretory phospholipase A2 is the principal bactericide for staphylococci and other gram-positive bacteria in human tears. Infect Immun (1998) 1.31
Antibacterial peptide from normal rat serum. 1. Isolation from whole serum, activity, and microbicidal spectrum. Biochemistry (1981) 1.30
Inhibition by sulfonamides of the candidacidal activity of human neutrophils. J Clin Invest (1971) 1.30